Free Trial

Rani Therapeutics (RANI) Insider Trading & Ownership

Rani Therapeutics logo
$2.47 -0.10 (-3.89%)
(As of 11/13/2024 ET)

Rani Therapeutics (NASDAQ:RANI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
53.30%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$77,540.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$20.73 M
Get RANI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RANI Insider Buying and Selling by Quarter

Rani Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/15/2024South Cone Investments LimitedMajor ShareholderSell3,829,360$2.65$10,147,804.00  
12/6/2023Talat ImranCEOBuy10,000$2.27$22,700.00  
12/4/2023Talat ImranCEOBuy5,000$2.57$12,850.00  
11/29/2023Talat ImranCEOBuy20,000$2.05$41,000.00  
11/24/2023Cortes Isidoro Alfonso QuirogaMajor ShareholderSell5,265,165$2.01$10,582,981.65  
11/16/2023Maulik NanavatyDirectorBuy500$1.98$990.00  
(Data available from 1/1/2013 forward)

RANI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Rani Therapeutics includes Cortes Isidoro Alfonso Quiroga, Maulik Nanavaty, Mir A Imran, South Cone Investments Limited, and Talat Imran. Learn more on insiders at RANI.

53.30% of Rani Therapeutics stock is owned by insiders. Learn more on RANI's insider holdings.

The following insiders have purchased RANI shares in the last 24 months: Maulik Nanavaty ($990.00), South Cone Investments Limited ($1,293,643.82), and Talat Imran ($76,550.00).

Insiders have purchased a total of 232,907 RANI shares in the last 24 months for a total of $1,371,183.82 bought.

The following insiders have sold RANI shares in the last 24 months: Cortes Isidoro Alfonso Quiroga ($10,582,981.65), and South Cone Investments Limited ($10,147,804.00).

Insiders have sold a total of 9,094,525 Rani Therapeutics shares in the last 24 months for a total of $20,730,785.65 sold.

Rani Therapeutics Key Executives

  • Mr. Mir A. Imran (Age 67)
    Executive Chairman
    Compensation: $80k
  • Mr. Talat Imran (Age 42)
    CEO & Director
    Compensation: $450k
  • Mr. Svai S. Sanford (Age 54)
    Chief Financial Officer
    Compensation: $416k
  • Dr. Mir Hashim (Age 64)
    Chief Scientific Officer
    Compensation: $416k
  • Mr. Eric Groen (Age 53)
    General Counsel
  • Ms. Bella Vazquez
    Vice President of Human Resources
  • Ms. Kate McKinley M.B.A. (Age 47)
    Chief Business Officer
  • Ms. Arvinder Dhalla
    Vice President of Clinical Development


This page (NASDAQ:RANI) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners